EC
AMLX icon

EntryPoint Capital’s Amylyx Pharmaceuticals AMLX Stock Holding History

EntryPoint Capital’s Portfolio AMLX Stock Details AMLX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-10,587
Closed -$37.5K – 604
2025
Q1 		$37.5K Sell
10,587
-3,322
-24% -$11.8K 0.02% 645
2024
Q4 		$52.6K Buy
+13,909
New +$52.6K 0.02% 689